Monday 3 August, 12.30-1.30pm

The Auditorium, Education Centre, Fairfield General Hospital

Dr Andrew Claxton will lead this session looking at a case series of patients managed on ICU with profound shock, that was refractory to standard ICU treatment. He will discuss the indications and evidence of novel and off-licence use of treatments such as high dose euglycaemic insulin therapy, methylene blue, and Vitamin B12.

This is the Teams link: https://bit.ly/NCAGR030826